Cook Jennifer E. has filed 18 insider transactions across 3 companies since November 2021.
Most recent transaction: a tax payment of 1805 shares of Jazz Pharmaceuticals plc ($JAZZ) on August 08, 2025.
Activity breakdown: 0 open-market purchases and 3 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug. 8, 2025 | Jazz Pharmaceuticals plc | $JAZZ | Cook Jennifer E. | Director | F | Ordinary Shares | 1805 | $111.25 | 10,837.0000 | 66,007,000 | 14.28% | 0.00% |
| Aug. 7, 2025 | Jazz Pharmaceuticals plc | $JAZZ | Cook Jennifer E. | Director | A | Ordinary Shares | 3507 | $0.00 | 12,642.0000 | 66,007,000 | 38.39% | 0.01% |
| June 20, 2025 | BridgeBio Pharma, Inc. | $BBIO | Cook Jennifer E. | Not found | A | Stock Option (Right to Buy) | 8425 | $0.00 | 8,425.0000 | 190,188,626 | 9999.99% | 0.00% |
| June 20, 2025 | BridgeBio Pharma, Inc. | $BBIO | Cook Jennifer E. | Not found | A | Common Stock | 6589 | $0.00 | 13,741.0000 | 190,188,626 | 92.13% | 0.00% |
| June 3, 2025 | Denali Therapeutics Inc. | $DNLI | Cook Jennifer E. | Director | A | Common Stock | 6037 | $0.00 | 26,075.0000 | 164,473,772 | 30.13% | 0.00% |
| June 3, 2025 | Denali Therapeutics Inc. | $DNLI | Cook Jennifer E. | Director | A | Stock Option (right to buy) | 18111 | $0.00 | 18,111.0000 | 164,473,772 | 9999.99% | 0.01% |
| Aug. 2, 2024 | Jazz Pharmaceuticals plc | $JAZZ | Cook Jennifer E. | Director | A | Ordinary Shares | 3731 | $0.00 | 10,619.0000 | 72,066,000 | 54.17% | 0.01% |
| Aug. 6, 2024 | Jazz Pharmaceuticals plc | $JAZZ | Cook Jennifer E. | Director | F | Ordinary Shares | 1484 | $111.35 | 9,135.0000 | 72,066,000 | 13.97% | 0.00% |
| June 21, 2024 | BridgeBio Pharma, Inc. | $BBIO | Cook Jennifer E. | Not found | A | Stock Option (Right to Buy) | 26014 | $0.00 | 26,014.0000 | 0 | 9999.99% | 0.00% |
| June 6, 2024 | Denali Therapeutics Inc. | $DNLI | Cook Jennifer E. | Director | S | Common Stock | 1458 | $21.73 | 20,038.0000 | 137,370,897 | 6.78% | 0.00% |
| May 31, 2024 | Denali Therapeutics Inc. | $DNLI | Cook Jennifer E. | Director | A | Stock Option (right to buy) | 17901 | $0.00 | 17,901.0000 | 137,370,897 | 9999.99% | 0.01% |
| May 31, 2024 | Denali Therapeutics Inc. | $DNLI | Cook Jennifer E. | Director | A | Common Stock | 5967 | $0.00 | 21,496.0000 | 137,370,897 | 38.42% | 0.00% |
| Dec. 4, 2023 | Jazz Pharmaceuticals plc | $JAZZ | Cook Jennifer E. | Director | S | Ordinary Shares | 417 | $119.27 | 6,888.0000 | 62,539,000 | 5.71% | 0.00% |
| Aug. 11, 2023 | Jazz Pharmaceuticals plc | $JAZZ | Cook Jennifer E. | Director | A | Ordinary Shares | 3075 | $0.00 | 8,546.0000 | 62,539,000 | 56.21% | 0.00% |
| Aug. 14, 2023 | Jazz Pharmaceuticals plc | $JAZZ | Cook Jennifer E. | Director | S | Ordinary Shares | 1241 | $138.16 | 7,305.0000 | 62,539,000 | 14.52% | 0.00% |
| June 21, 2023 | BridgeBio Pharma, Inc. | $BBIO | Cook Jennifer E. | Director | A | Stock Option (right to buy) | 51501 | $0.00 | 51,501.0000 | 0 | 9999.99% | 0.00% |
| Nov. 16, 2021 | BridgeBio Pharma, Inc. | $BBIO | Cook Jennifer E. | Director | M | Common Stock | 3576 | $0.00 | 7,152.0000 | 0 | 100.00% | 0.00% |
| Nov. 16, 2021 | BridgeBio Pharma, Inc. | $BBIO | Cook Jennifer E. | Director | M | Restricted Stock Units | 3576 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |